Sign In  |  Register  |  About Mill Valley  |  Contact Us

Mill Valley, CA
September 01, 2020 1:29pm
7-Day Forecast | Traffic

  • Search Hotels in Mill Valley

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Sutro Biopharma Inc (NQ: STRO )

3.545 +0.135 (+3.96%)
Streaming Delayed Price Updated: 1:14 PM EST, Dec 8, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 521,747
Open 3.370
Bid (Size) 3.540 (10)
Ask (Size) 3.550 (5)
Prev. Close 3.410
Today's Range 3.330 - 3.665
52wk Range 2.005 - 8.720
Shares Outstanding 60,416,916
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Vaxcyte Exercises Option and Enters into Manufacturing Rights Agreement with Sutro Biopharma to Obtain Control Over Manufacturing and Development of Cell-Free Extract for its Vaccine Candidates
From Vaxcyte, Inc.
Via GlobeNewswire

Performance

YTD
-55.80%
-55.80%
1 Month
+35.31%
+35.31%
3 Month
-21.92%
-21.92%
6 Month
-34.47%
-34.47%
1 Year
-53.11%
-53.11%

More News

Read More
Expert Ratings for Sutro Biopharma
Via Benzinga
Where Sutro Biopharma Stands With Analysts
Via Benzinga
Sutro Biopharma's Lead Ovarian Cancer Candidate Is A Game Changer, Analyst Sees Huge Upside
Via Benzinga
5 Analysts Have This to Say About Sutro Biopharma
Via Benzinga
Where Sutro Biopharma Stands With Analysts
Via Benzinga
6 Analysts Have This to Say About Sutro Biopharma
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 6, 2023
Via Benzinga
Why Monro Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Sutro Biopharma Earnings Perspective: Return On Capital Employed
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
Via Benzinga
Where Sutro Biopharma Stands With Analysts
Via Benzinga
Sutro Biopharma Posts Updated Data From Ovarian Cancer Candidate
Via Benzinga
Recap: Sutro Biopharma Q2 Earnings
Via Benzinga
Short Volatility Alert: Sutro Biopharma, Inc.
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
Super Micro Computer, Rayonier Advanced Materials And Some Other Big Stocks Moving Lower On Tuesday
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Why Investors Are Suddenly Excited About Vaxcyte
Via MarketBeat
Exposures COVID-19
Why Tricida Shares Dipped Around 95%; Here Are 73 Biggest Movers From Yesterday
Via Benzinga
Avis Budget, Scholastic And Other Big Gainers From Monday
Via Benzinga
Sutro Biopharma Earnings Perspective: Return On Capital Employed
Via Benzinga
Daily Biotech Pulse: Teva's Opioids Settlement, Criminal Investigation Against Cassava, Durable Responses For IN8bio's Leukemia Therapy
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 MillValley.com & California Media Partners, LLC. All rights reserved.